AAMU
CRL icon

Amundi Asset Management US’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$33.3M Buy
114,950
+10,244
+10% +$2.97M 0.03% 528
2020
Q4
$26.2M Buy
104,706
+18,158
+21% +$4.54M 0.02% 556
2020
Q3
$19.6M Buy
86,548
+79,852
+1,193% +$18.1M 0.02% 554
2020
Q2
$1.17M Buy
6,696
+1,831
+38% +$319K ﹤0.01% 1154
2020
Q1
$614K Buy
4,865
+914
+23% +$115K ﹤0.01% 1163
2019
Q4
$604K Hold
3,951
﹤0.01% 1305
2019
Q3
$523K Sell
3,951
-37,640
-91% -$4.98M ﹤0.01% 1301
2019
Q2
$5.9M Buy
41,591
+37,252
+859% +$5.29M ﹤0.01% 891
2019
Q1
$630K Sell
4,339
-38,321
-90% -$5.56M ﹤0.01% 1267
2018
Q4
$4.83K Buy
42,660
+17,222
+68% +$1.95K ﹤0.01% 837
2018
Q3
$3.42M Buy
+25,438
New +$3.42M ﹤0.01% 999
2018
Q2
Sell
-17,159
Closed -$1.83M 1577
2018
Q1
$1.83M Sell
17,159
-172,911
-91% -$18.5M ﹤0.01% 1078
2017
Q4
$20.8M Buy
190,070
+58,409
+44% +$6.39M 0.03% 449
2017
Q3
$14.2M Buy
131,661
+32,551
+33% +$3.52M 0.05% 252
2017
Q2
$10M Sell
99,110
-64,615
-39% -$6.54M 0.03% 314
2017
Q1
$14.7M Sell
163,725
-698
-0.4% -$62.8K 0.05% 252
2016
Q4
$12.5M Sell
164,423
-133,286
-45% -$10.2M 0.04% 271
2016
Q3
$24.8M Buy
297,709
+25,983
+10% +$2.17M 0.09% 192
2016
Q2
$22.4M Sell
271,726
-21,772
-7% -$1.79M 0.08% 196
2016
Q1
$22.3M Buy
293,498
+1,153
+0.4% +$87.6K 0.08% 193
2015
Q4
$23.5M Sell
292,345
-462
-0.2% -$37.1K 0.09% 194
2015
Q3
$18.6M Buy
292,807
+47,945
+20% +$3.05M 0.08% 238
2015
Q2
$17.2M Buy
244,862
+42,767
+21% +$3.01M 0.06% 269
2015
Q1
$16M Sell
202,095
-41,279
-17% -$3.27M 0.06% 287
2014
Q4
$15.5M Buy
243,374
+21,758
+10% +$1.38M 0.06% 294
2014
Q3
$13.2M Buy
221,616
+98,439
+80% +$5.88M 0.05% 303
2014
Q2
$6.59M Sell
123,177
-40,690
-25% -$2.18M 0.03% 416
2014
Q1
$9.89M Buy
163,867
+32,658
+25% +$1.97M 0.04% 341
2013
Q4
$6.96M Buy
131,209
+29,997
+30% +$1.59M 0.03% 397
2013
Q3
$4.68M Buy
101,212
+55,312
+121% +$2.56M 0.02% 467
2013
Q2
$1.88M Buy
+45,900
New +$1.88M 0.01% 540